186
Participants
Start Date
January 31, 2012
Primary Completion Date
April 30, 2014
Study Completion Date
April 30, 2014
ropinirole monotherapy
ropinirole as monotherapy in Parkinson's disease
placebo monotherapy
placebo as monotherapy in Parkinson's disease
GSK Investigational Site, Tallinn
GSK Investigational Site, Forest Hills
GSK Investigational Site, Tallinn
GSK Investigational Site, Richmond
GSK Investigational Site, Augusta
GSK Investigational Site, Boca Raton
GSK Investigational Site, Tampa
GSK Investigational Site, Cincinnati
GSK Investigational Site, Tartu
GSK Investigational Site, Torrance
GSK Investigational Site, Pasadena
GSK Investigational Site, Reseda
GSK Investigational Site, Fountain Valley
GSK Investigational Site, Ventura
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Smolensk
GSK Investigational Site, Kursk
GSK Investigational Site, Saratov
GSK Investigational Site, Kazan'
GSK Investigational Site, Ufa
GSK Investigational Site, Chelyabinsk
GSK Investigational Site, Sungnam -Gyeonggi-do
GSK Investigational Site, Donggu Gwangju
GSK Investigational Site, Perm
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Novosibirsk
GSK Investigational Site, Omsk
GSK Investigational Site, Krasnoyarsk
GSK Investigational Site, Banská Bystrica
GSK Investigational Site, Bratislava
GSK Investigational Site, Bratislava
GSK Investigational Site, Busan
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
Lead Sponsor
GlaxoSmithKline
INDUSTRY